OBJECTIVES: Evidence-based mindfulness programs have well-established benefits, but the potential for harmful effects is understudied. We explored the frequency and severity of unpleasant experiences and harm in two nonclinical samples participating in an adaptation of mindfulness-based cognitive therapy (MBCT) for the general population. METHODS: Study 1 included 84 schoolteachers; study 2 included 74 university students. Both studies were uncontrolled. Participants completed self-report questionnaires about psychological symptoms before and after the 8-week mindfulness course. After the course, they responded to a survey designed for this study that included Likert ratings and free-text questions about unpleasant experiences and harm. All data were collected online. RESULTS: In both samples, about two-thirds of participants reported unpleasant experiences associated with mindfulness practice during the course. Most participants (85-92%) rated these experiences as not at all or somewhat upsetting; some indicated that difficult experiences led to important learning or were beneficial in some way. The proportion of participants reporting harm from the mindfulness course ranged from 3 to 7%. The proportion showing reliable deterioration on symptom questionnaires ranged from 2 to 7%. Those reporting harm and those showing reliable deterioration on questionnaires were largely separate subgroups; only one participant fell in both. CONCLUSIONS: Findings highlight the need for mindfulness teachers to manage expectations about benefits and difficulties that may occur in mindfulness-based programs and to work skilfully with participants experiencing difficulties. Experiences of harm may not be captured by symptom questionnaires and should be explicitly assessed in other ways. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12671-020-01547-8.
OBJECTIVES: Evidence-based mindfulness programs have well-established benefits, but the potential for harmful effects is understudied. We explored the frequency and severity of unpleasant experiences and harm in two nonclinical samples participating in an adaptation of mindfulness-based cognitive therapy (MBCT) for the general population. METHODS: Study 1 included 84 schoolteachers; study 2 included 74 university students. Both studies were uncontrolled. Participants completed self-report questionnaires about psychological symptoms before and after the 8-week mindfulness course. After the course, they responded to a survey designed for this study that included Likert ratings and free-text questions about unpleasant experiences and harm. All data were collected online. RESULTS: In both samples, about two-thirds of participants reported unpleasant experiences associated with mindfulness practice during the course. Most participants (85-92%) rated these experiences as not at all or somewhat upsetting; some indicated that difficult experiences led to important learning or were beneficial in some way. The proportion of participants reporting harm from the mindfulness course ranged from 3 to 7%. The proportion showing reliable deterioration on symptom questionnaires ranged from 2 to 7%. Those reporting harm and those showing reliable deterioration on questionnaires were largely separate subgroups; only one participant fell in both. CONCLUSIONS: Findings highlight the need for mindfulness teachers to manage expectations about benefits and difficulties that may occur in mindfulness-based programs and to work skilfully with participants experiencing difficulties. Experiences of harm may not be captured by symptom questionnaires and should be explicitly assessed in other ways. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12671-020-01547-8.
Authors: Simon B Goldberg; Raymond P Tucker; Preston A Greene; Richard J Davidson; Bruce E Wampold; David J Kearney; Tracy L Simpson Journal: Clin Psychol Rev Date: 2017-11-08
Authors: Marcelo M P Demarzo; Jesús Montero-Marin; Pim Cuijpers; Edurne Zabaleta-del-Olmo; Kamal R Mahtani; Akke Vellinga; Caterina Vicens; Yolanda López-del-Hoyo; Javier García-Campayo Journal: Ann Fam Med Date: 2015-11 Impact factor: 5.166
Authors: Catherine Crane PhD; Poushali Ganguli PhD; Susan Ball MSc; Laura Taylor PhD; Sarah-Jayne Blakemore PhD; Sarah Byford PhD; Tim Dalgleish PhD; Tamsin Ford PhD; Mark Greenberg PhD; Willem Kuyken PhD; Liz Lord Ma; Jesus Montero-Marin PhD; Anna Sonley MEd; Obioha C Ukoumunne PhD; J Mark G Williams PhD Journal: Glob Adv Health Med Date: 2020-12-15
Authors: Willem Kuyken; Fiona C Warren; Rod S Taylor; Ben Whalley; Catherine Crane; Guido Bondolfi; Rachel Hayes; Marloes Huijbers; Helen Ma; Susanne Schweizer; Zindel Segal; Anne Speckens; John D Teasdale; Kees Van Heeringen; Mark Williams; Sarah Byford; Richard Byng; Tim Dalgleish Journal: JAMA Psychiatry Date: 2016-06-01 Impact factor: 21.596
Authors: Imke Hanssen; Vera Scheepbouwer; Marloes Huijbers; Eline Regeer; Marc Lochmann van Bennekom; Ralph Kupka; Anne Speckens Journal: PLoS One Date: 2021-11-04 Impact factor: 3.240
Authors: Kate Tudor; Shannon Maloney; Anam Raja; Ruth Baer; Sarah-Jayne Blakemore; Sarah Byford; Catherine Crane; Tim Dalgleish; Katherine De Wilde; Tamsin Ford; Mark Greenberg; Verena Hinze; Liz Lord; Lucy Radley; Emerita Satiro Opaleye; Laura Taylor; Obioha C Ukoumunne; Russell Viner; Willem Kuyken; Jesus Montero-Marin Journal: Prev Sci Date: 2022-03-10